Literature DB >> 4564282

Comparative immunogenicity of heat-killed and living oral Salmonella vaccines.

F M Collins, P B Carter.   

Abstract

CD-1 mice were vaccinated intragastrically or intramuscularly with one or two doses of 200 mug of heat-killed Salmonella enteritidis 5694. Control mice were vaccinated with sublethal doses of living S. enteritidis Se795. The mice were challenged intragastrically with approximately 10(6)S. enteritidis 5694 SM(R) 7 to 14 days later, and the growth of the challenge population in the liver, spleen, mesenteric lymph nodes, lungs, and intestine was measured quantitatively. Mice receiving two doses of heat-killed vaccine by mouth were able to delay the systemic emergence of a gastrically introduced salmonella infection by 1 to 2 days. The corresponding liver and spleen populations were slightly lower than those seen in the normal controls. On the other hand, mice receiving the living, attenuated vaccine (either intravenously or intragastrically) developed an effective anti-salmonella immunity against subsequent reinfection.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4564282      PMCID: PMC422558          DOI: 10.1128/iai.6.4.451-458.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  THE EFFECT OF THE GROWTH RATE ON THE COMPOSITION OF S. ENTERITIDIS CELL WALLS.

Authors:  F M COLLINS
Journal:  Aust J Exp Biol Med Sci       Date:  1964-04

2.  The initial effort to immunize American soldier volunteers with typhoid vaccine.

Authors:  W D TIGERTT
Journal:  Mil Med       Date:  1959-05       Impact factor: 1.437

3.  Oral immunization against experimental salmonellosis I. Development of temperature-sensitive mutant vaccines.

Authors:  K J Fahey; G N Cooper
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

Review 4.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

5.  [Oral immunization with nonvial microorganism or their antigens. Immunogenicity of various inactivated S. typhimurium full antigens in the mouse protection test].

Authors:  I Kordes; B Kordes; H Pichl; B Ganze; H Raettig
Journal:  Zentralbl Bakteriol Orig A       Date:  1971-06

6.  Immune response of the hamster to oral and parenteral immunization.

Authors:  J Dolezel; J Bienenstock
Journal:  Cell Immunol       Date:  1971-08       Impact factor: 4.868

7.  Effectiveness of oral killed typhoid vaccine.

Authors:  C S Chuttani; K Prakash; A Vergese; U Sharma; P Singha; B G Ray
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Study of live typhoid vaccine in chimpanzees.

Authors:  B Cvjetanović; D M Mel; O Felsenfeld
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  Oral Immunization in Experimental Salmonellosis III. Behavior of Virulent and Temperature-Sensitive Mutant Strains in the Intestinal Tissues of Rats.

Authors:  G N Cooper; K J Fahey
Journal:  Infect Immun       Date:  1970-08       Impact factor: 3.441

10.  Studies on infection and immunity in experimental typhoid fever. II. Susceptibility of recovered animals to re-exposure.

Authors:  S GAINES; J G TULLY; W D TIGERTT
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

View more
  23 in total

Review 1.  Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.

Authors:  Raphael Simon; Sharon M Tennant; James E Galen; Myron M Levine
Journal:  Vaccine       Date:  2011-05-25       Impact factor: 3.641

Review 2.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

Review 3.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

4.  Growth of Pasteurella multocida in vaccinated and normal mice.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1973-12       Impact factor: 3.441

5.  Pathogenecity of Yersinia enterocolitica for mice.

Authors:  P B Carter
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

6.  Effect of vaccination of hens with an avirulent strain of Salmonella typhimurium on immunity of progeny challenged with wild-Type Salmonella strains.

Authors:  J O Hassan; R Curtiss
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

7.  Immunogenicity of living and heat-killed Salmonella pullorum vaccines.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

8.  Variability of protection in inbred mice induced by a ribosomal vaccine prepared from Salmonella typhimurium.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

9.  Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.

Authors:  M M Levine; D Herrington; J R Murphy; J G Morris; G Losonsky; B Tall; A A Lindberg; S Svenson; S Baqar; M F Edwards
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

10.  Growth of salmonellae in orally infected germfree mice.

Authors:  F M Collins; P B Carter
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.